How Much Did Daye Raise?
Funding & Key Investors

Daye, a London-based period care subscription service, has secured significant enterprise-level funding, with its total funding reaching $11.5M. The company recently announced a major strategic investment of $11.5M, underscoring its growth trajectory in the competitive femtech market. This latest capital infusion is expected to fuel further expansion and product development.

What is Daye?

Daye
ManufacturingCosmetics, Beauty Supply & Personal Care ProductsRetail

Headquartered in London, Daye operates on a monthly subscription model, delivering sustainable and organic period care products directly to consumers. Their product line includes standard and CBD-infused tampons, alongside 'ProViotics' aimed at enhancing vaginal health. Beyond its core offerings, Daye is actively engaged in initiatives to address gender biases within medical research and product innovation, positioning itself as a multifaceted player in women's health and wellness.

How much funding has Daye raised?

Daye has raised a total of $11.5M across 1 funding round:

2022

Series A

$11.5M

Series A (2022): $11.5M with participation from MassMutual Ventures, Hambro Perks, and Cross-Border Impact Ventures

Key Investors in Daye

Hambro Perks

Hambro Perks is a London-headquartered international investment firm focused on private technology investing, partnering with founders to support growth businesses across various stages of the investment cycle.

Cross-Border Impact Ventures

Cross-Border Impact Ventures is an impact venture capital firm dedicated to investing in transformative health technology companies, particularly those addressing women's, children's, and adolescent health markets, with a focus on sexual and reproductive health.

MassMutual Ventures

MassMutual Ventures is an investor participating in the funding round, contributing to Daye's strategic growth and expansion initiatives.

What's next for Daye?

With a recent major strategic investment and a substantial overall funding base of $11.5M, Daye is poised for significant scaling. The company's focus on sustainable period care and innovative health solutions, such as CBD-infused tampons and vaginal probiotics, aligns with growing consumer demand for health-conscious and eco-friendly products. Future strategic moves will likely involve expanding their product portfolio, enhancing their subscription service, and potentially broadening their market reach, leveraging this latest capital to solidify their position and drive further innovation in the femtech sector.

See full Daye company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Aerospace & DefenseManufacturingConsumer ServicesRepair Services
Automotive PartsManufacturing
Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturingAerospace & Defense

Frequently Asked Questions Regarding Daye Financial Insights

What are the most recent funding rounds that Daye has completed, and what were the funding rounds?
Daye has recently completed 1 funding rounds: Series A on Oct 26, 2022.
What is the total amount of funding Daye has raised to date?
Daye has raised a total of $11.5M in funding to date.
How many funding rounds has Daye completed?
Daye has completed 1 funding rounds.
How much funding did Daye raise in its most recent funding round?
Daye raised $11.5M in its most recent funding round.
Who are the lead investors in Daye's latest funding round?
The lead investor in Daye's latest funding round was MassMutual Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Daye's history?
The largest funding round in Daye's history was $11.5M.
See more information about Daye